Nurix Therapeutics, Inc. NRIX Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $6.25M-66.1% | $13.58M+2.2% | $7.89M-37.3% | $44.06M+264% | $18.45M+11.3% | ||
| $84.14M+20.8% | $83.02M+23.5% | $86.12M+55.2% | $78.1M+59.6% | $69.66M+39.3% | ||
| $14.61M+25.4% | $13.65M+27.3% | $13.16M+12.3% | $14.28M+22.0% | $11.65M-1.2% | ||
| $98.75M+21.4% | $96.67M+24.0% | $99.28M+47.7% | $92.38M+52.4% | $81.32M+31.6% | ||
| $98.75M+21.4% | $96.67M+24.0% | $99.28M+47.7% | $92.38M+52.4% | $81.32M+31.6% | ||
| -$92.5M-47.1% | -$83.1M-28.5% | -$91.39M-67.3% | -$48.32M+0.4% | -$62.86M-39.0% | ||
| -1,479.4%-1,139pp | -612%-125pp | -1,157.7%-724pp | -109.7%+292pp | -340.7%-68.0pp | ||
| $5.32M-18.3% | $4.87M-20.3% | $4.96M-13.5% | $5.62M+37.6% | $6.51M+71.8% | ||
| -$87.17M-54.7% | -$78.22M-33.6% | -$86.42M-76.5% | -$43.46M+2.4% | -$56.35M-35.7% | ||
| -1,394.3%-1,089pp | -576.1%-135pp | -1,094.8%-706pp | -98.7%+270pp | -305.4%-55.0pp | ||
| -$0.79-17.9% | -$0.83-10.7% | -$1.03-53.7% | -$0.52+26.8% | -$0.67+11.8% | ||
| -$0.79-17.9% | -$0.83-10.7% | -$1.03-53.7% | -$0.52+26.8% | -$0.67+11.8% | ||
| 110.1M+31.7% | 86.7M+29.1% | 84.2M+15.6% | 83.9M+34.5% | 83.6M+52.2% | ||
| 110.1M+31.7% | 86.7M+29.1% | 84.2M+15.6% | 83.9M+34.5% | 83.6M+52.2% | ||
| $5.32M-18.3% | $4.87M-20.3% | $4.96M-13.5% | $5.62M+37.6% | $6.51M+71.8% | ||
| $6.25M-66.1% | $13.58M+2.2% | $7.89M-37.3% | $44.06M+264% | $18.45M+11.3% | ||
| -$92.5M-47.1% | -$83.1M-28.5% | -$91.39M-67.3% | -$48.32M+0.4% | -$62.86M-39.0% | ||
| -$90.3M-49.2% | -$80.98M-30.4% | -$89.36M-71.1% | -$46.08M+0.3% | -$60.51M-40.2% | ||
| -$90.3M-49.2% | -$80.98M-30.4% | -$89.36M-71.1% | -$46.08M+0.3% | -$60.51M-40.2% | ||
| -1,444.3%-1,116pp | -596.4%-129pp | -1,132%-717pp | -104.6%+278pp | -327.9%-67.6pp | ||
| -$92.5M-47.1% | -$83.1M-28.5% | -$91.39M-67.3% | -$48.32M+0.4% | -$62.86M-39.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Nurix Therapeutics, Inc.'s income statement data come from?
- Every line is extracted from Nurix Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.